293b cpd has been researched along with glimepiride in 1 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (glimepiride) | Trials (glimepiride) | Recent Studies (post-2010) (glimepiride) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 956 | 340 | 474 |
| Protein | Taxonomy | 293b cpd (IC50) | glimepiride (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 6.39 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.85 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 6.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocchetti, M; Rosati, B; Wanke, E; Zaza, A | 1 |
1 other study(ies) available for 293b cpd and glimepiride
| Article | Year |
|---|---|
Sulfonylureas blockade of neural and cardiac HERG channels.
Topics: Action Potentials; Animals; Cation Transport Proteins; Chromans; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glyburide; Guinea Pigs; Humans; Inhibitory Concentration 50; Mice; Myocardium; Neuroblastoma; Neurons; Nisoldipine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Sulfonamides; Sulfonylurea Compounds; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured | 1998 |